Application of expression genomics in drug development and genomic medicine

Drug Development Research

Volumn 62, Issue 2, 2004, Pages 124-133

  Chin, Khew Voon ^a,f   Selvanayagam, Zachariah E ^b   Vittal, Ragini ^a   Kita, Tsunekazu ^c   Kudoh, Kazuya ^c   Yang, Chung S ^a   Wong, Yick Fu ^d   Cheung, Tak Hong ^d   Yeo, Winnie ^d   Chung, Tony Kwok Hung ^d   Lin, Yong ^b   Liao, Jason ^b   Shih, Joe Weichung ^b   Yap, Sook Fan ^e   Lin, Albert W ^f  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF MALAYA   (Malaysia)

^f Imhoteq Co   (United States)

Author keywords

Genomic medicine; Microarray; Personalized; Predictive; Systems biology

Indexed keywords

ABC TRANSPORTER; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIGALLOCATECHIN GALLATE; FK 506 BINDING PROTEIN; HYDROGEN PEROXIDE; PACLITAXEL; POLYPHENOL DERIVATIVE;

CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RESISTANCE; DNA MICROARRAY; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; OVARY CANCER; PHARMACOGENOMICS; PREDICTION; REVIEW; TEA; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 9644265436     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10375     Document Type: Review

References (61)

1. Adams MD, Dubnick M, Kerlavage AR, Moreno R, Kelley JM, Utterback TR, Nagle JW, Fields C, Venter JC. 1992. Sequence identification of 2,375 human brain genes. Nature 355:632-634.
2. Ahn WS, Huh SW, Bae SM, Lee IP, Lee JM, Namkoong SE, Kim CK, Sin JI. 2003. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell Biol 22:217-224.
3. Alizadeh AA, Eisen MB, Davis RE, Ma C, Losses IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
4. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al. 2002. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816-824.
5. Brazhnik P, de la Fuente A, Mendes P. 2002. Gene networks: how to put the function in genomics. Trends Biotechnol 20:467-472.
6. Brown PO, Botstein D. 1999. Exploring the new world of the genome with DNA microarrays. Nat Genet 21(1 Suppl):33-37.
7. Cao Y, Cao R. 1999. Angiogenesis inhibited by drinking tea. Nature 398:381.
8. Chee M, Yung R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SP. 1996. Accessing genetic information with high-density DNA arrays. Science 274:610-614.
9. Chin KV, Seifer DB, Feng B, Lin Y, Shili WC. 2002. DNA microarray analysis of the expression profiles of luteinized granulosa cells as a function of ovarian reserve. Fertil Steril 77:1214-1218.
10. Chung JY, Huang C, Meng X, Dong Z, Yang CS. 1999. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res 59:4610-4617.
11. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. 2001. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. Faseb J 15:2022-2024.
12. Dashwood WM, Orner GA, Dashwood RH. 2002. Inhibition of beta-eatenin/Tef activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun 296:584-588.
13. Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, et al. 2003. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 31:219-223.
14. Doherty MM, Michael M. 2003. Tumoral drug metabolism: perspectives and therapeutic implications. Curr Drug Metab 4:131-149.
15. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
16. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537.
17. Gottesman MM, Fojo T, Bates SE. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48-58.
18. Hong J, Lu H, Meng X, Ryu JH, Hara Y, Yang CS. 2002. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3- gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 62:7241-7246.
19. Hood L. 2003. Systems biology: integrating technology, biology, and computation. Mech Ageing Dev 124:9-16.
20. Imanishi T, Itoh T, Suzuki Y, O'Donovan C, Fukuchi S, Koyanagi KO, Barrero RA, Tamura T, Yamaguchi-Kabata Y, Tanino M, et al. 2004. Integrative annotation of 21,037 human genes validated by full-length cDNA clones. PLoS Biol 2:E162.
21. Isemura M, Saeki K, Kimura T, Hayakawa S, Minami T, Sazuka M. 2000. Tea catechins and related polyphenols as anti-cancer agents. Biofactors 13:81-85.
22. Islam S, Islam N, Kermode T, Johnstone B, Mukhtar H, Moskowitz, RW, Goldberg VM, Malemud CJ, Haqqi TM. 2000. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 270:793-797.
23. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr., Boguski MS, et al. 1999. The transcriptional program in the response of human fibroblasts to serum. Science 283:83-87.
24. Kohlmeier L, Weterings KG, Steck S, Kok FJ. 1997. Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr Cancer 27:1-13.
25. Konstantinov IE, Coles JG, Boscarino C, Takahashi M, Goncalves J, Ritter J, Van Arsdell GS. 2004. Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions. J Thorac Cardiovasc Surg 127:746-754.
26. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV. 2000. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 60:4161-4166.
27. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
28. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, Vidalain PO, Han JD, Chesneau A, Hao T, et al. 2004. A map of the interactome network of the metazoan C. elegans. Science 303:540-543.
29. Liang YC, Chen YC, Lin YL, Lin-Shiau SY, Ho CT, Lin JK. 1999. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate. Carcinogenesis 20:733-736.
30. Liem AA, Chamberlain MP, Wolf CR, Thompson AM. 2002. The role of signal transduction in cancer treatment and drug resistance. Eur J Surg Oncol 28:679-684.
31. Lin JK, Liang YC, Lin-Shiau SY. 1999. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol 58:911-915.
32. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and others. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680.
33. Long LH, Clement MV, Halliwell B. 2000. Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem Biophys Res Commun 273:50-53.
34. Naasani I, Seimiya H, Tsuruo T. 1998. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Commun 249:391-396.
35. Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, Tsuruo T. 2003. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 63:824-830.
36. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. 2003. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112:1195-1202.
37. Ozols HF. 2000. Management of advanced ovarian cancer consensus summary. Advanced Ovarian Cancer Consensus Faculty. Semin Oncol 27(Suppl 7):47-49.
38. Paschka AG, Butler R, Young CY. 1998. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130:1-7.
39. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, et al. 2002. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947.
40. Schena M, Shalon D, Davis RW, Brown PO. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
41. Schmitt CA, Lowe SW. 2002. Apoptosis and chemoresistance in transgenic cancer models. J Mol Med 80:137-146.
42. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW. 1998. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol 16:301-306.
43. Selvanayagam ZE, Cheung TH, Wei N, Vittal R, Lo KWK, Yeo W, Kita T, Ravatn R, Chung TKH, Wong YF, Chin KV. 2004. Prediction of chemotherapeutic response in ovarian cancer by DNA microarray expression profiling. Cancer Genet Cytogenet (in press).
44. Sharma R, Awasthi YC, Yang Y, Sharma A, Singhal SS, Awasthi S. 2003. Energy dependent transport of xenobiotics and its relevance to multidrug resistance. Curr Cancer Drug Targets 3:89-107.
45. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B. 1998. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 9:3273-3297.
46. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, Haga N. 2003. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 94:15-21.
47. Uetz P, Giot L, Cagney G, Mansfield TA, Judson HS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, et al. 2000. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-627.
48. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al. 2002. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009.
49. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
50. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
51. Ventura C, Maioli M. 2001. Protein kinase C control of gene expression. Crit Rev Eukaryot Gene Exp 11:243-267.
52. Vittal R, Selvamayagam ZE, Hong J, Liu F, Chin KV, Yang CS. 2004. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3- gallate in human bronchial epithelial 21 BES cells analyzed by DNA microarray. Mol Cancer Ther (in press).
53. Walhout AJ, Vidal M. 1999. A genetic strategy to eliminate self-activator baits prior to high-throughput yeast two-hybrid screens. Genome Res 9:1128-1134.
54. Weston AD, Hood L. 2004. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 3:179-196.
55. Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, et al. 2003. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 9:5486-5492.
56. Wyrick JJ, Young RA. 2002. Deciphering gene expression regulatory networks. Curr Opin Genet Dev 12:130-136.
57. Yang CS, Wang ZY. 1993. Tea and cancer. J Natl Cancer Inst 85:1038-1049.
58. Yang CS, Maliakal P, Meng X. 2002. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25-54.
59. Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. 1998a. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19:611-616.
60. Yang GY, Liao J, Li C, Chung J, Yurkow EJ, Ho CT, Yang CS. 2000. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 21:2035-2039.
61. Zheng X, Ravatn R, Lin Y, Shih WC, Rabson A, Strair R, Huberman E, Conney A, Chin KV. 2002. Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis. Nucleic Acids Res 30:4489-4499.